Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Spinal Fusion | 2 | 2007 | 76 | 0.40 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.37 | Why? |
| Internal Fixators | 1 | 2007 | 5 | 0.36 | Why? |
| Odontoid Process | 1 | 2007 | 6 | 0.36 | Why? |
| Bone Screws | 1 | 2007 | 30 | 0.35 | Why? |
| HIV-1 | 2 | 2021 | 3365 | 0.32 | Why? |
| Antibody Affinity | 2 | 2021 | 1078 | 0.31 | Why? |
| Spinal Injuries | 1 | 2006 | 82 | 0.31 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.31 | Why? |
| Spinal Fractures | 1 | 2007 | 124 | 0.30 | Why? |
| Antibodies, Neutralizing | 12 | 2021 | 25288 | 0.29 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.25 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.22 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.20 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.20 | Why? |
| B-Lymphocytes | 4 | 2021 | 4418 | 0.19 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.19 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.17 | Why? |
| Spike Glycoprotein, Coronavirus | 11 | 2021 | 37182 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.16 | Why? |
| Antigens, Viral | 4 | 2021 | 6298 | 0.16 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.14 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.14 | Why? |
| Antibodies, Monoclonal | 7 | 2021 | 8041 | 0.14 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.14 | Why? |
| Intestines | 1 | 2021 | 817 | 0.14 | Why? |
| Thromboembolism | 1 | 2006 | 2101 | 0.13 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.12 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.12 | Why? |
| Extracellular Matrix Proteins | 1 | 2012 | 95 | 0.12 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.11 | Why? |
| Epitopes | 5 | 2021 | 4113 | 0.11 | Why? |
| Venous Thrombosis | 1 | 2006 | 2739 | 0.11 | Why? |
| Tissue Engineering | 1 | 2012 | 190 | 0.10 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.10 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.10 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Biosensing Techniques | 1 | 2021 | 2116 | 0.08 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.08 | Why? |
| Pulmonary Embolism | 1 | 2006 | 4775 | 0.08 | Why? |
| Decompression, Surgical | 1 | 2006 | 114 | 0.08 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Intraoperative Complications | 1 | 2006 | 221 | 0.07 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.07 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.07 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Immunomodulation | 1 | 2012 | 1472 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.06 | Why? |
| Interferometry | 1 | 2021 | 74 | 0.06 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2021 | 93 | 0.06 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Chimera | 1 | 2020 | 83 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Protein Isoforms | 1 | 2020 | 347 | 0.05 | Why? |
| Genes, Reporter | 1 | 2020 | 472 | 0.05 | Why? |
| Activities of Daily Living | 1 | 2007 | 1530 | 0.05 | Why? |
| Reassortant Viruses | 1 | 2020 | 287 | 0.05 | Why? |
| Protein Array Analysis | 1 | 2020 | 387 | 0.04 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.04 | Why? |
| Postoperative Complications | 2 | 2007 | 5861 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.04 | Why? |
| HEK293 Cells | 2 | 2020 | 8394 | 0.04 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.04 | Why? |
| Animals | 3 | 2021 | 78931 | 0.04 | Why? |
| Selection, Genetic | 1 | 2020 | 691 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.04 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.04 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| Patient Satisfaction | 1 | 2007 | 2517 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Lymphocyte Culture Test, Mixed | 1 | 2012 | 6 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| CD28 Antigens | 1 | 2012 | 39 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Male | 8 | 2021 | 367725 | 0.03 | Why? |
| CD3 Complex | 1 | 2012 | 237 | 0.03 | Why? |
| Aging | 1 | 2007 | 3581 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.03 | Why? |
| Software | 1 | 2021 | 2501 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Child | 2 | 2007 | 70012 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Age Factors | 1 | 2007 | 21039 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Cell Proliferation | 1 | 2012 | 1973 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Child, Preschool | 1 | 2006 | 36283 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Treatment Outcome | 1 | 2007 | 51732 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2007 | 25144 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Risk Factors | 1 | 2006 | 71621 | 0.01 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2012 | 4545 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2007 | 88759 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Retrospective Studies | 1 | 2007 | 105322 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2012 | 5837 | 0.01 | Why? |
| Cytokines | 1 | 2012 | 15010 | 0.01 | Why? |
Gaebler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(143)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_